Quantitative analysis of gene expression in fixed colorectal carcinoma samples as a method for biomarker validation.

Biomarkers have been described as the future of oncology. Modern proteomics provide an invaluable tool for the near‑whole proteome screening for proteins expressed differently in neoplastic vs. healthy tissues.